scholarly journals CLINICAL AND HISTOPATHOLOGICAL EVALUATION OF EYELID LESIONS: RETROSPECTIVE ANALYSIS OF TERTIARY MEDICAL CENTER REFERRALS

2021 ◽  
Vol 8 (3) ◽  
pp. 107-110
Author(s):  
Mustafa Ömer İzzettinoğlu ◽  
Fatih Erkan Akay ◽  
Rüveyde Garip
Keyword(s):  
Retrospective Analysis ◽  
Medical Center ◽  
Histopathological Evaluation ◽  
Eyelid Lesions

scholarly journals A retrospective analysis of 44 patients with granuloma annulare during an 11-year period from a tertiary medical center in south Taiwan

2016 ◽  
Vol 34 (3) ◽  
pp. 121-125 ◽  
Author(s):  
Yu-Wen Cheng ◽  
Wen-Chien Tsai ◽  
Fu-Chen Chuang ◽  
Erick Chern ◽  
Chih-Hung Lee ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Medical Center ◽  
Granuloma Annulare

scholarly journals Soft catheters reduce the risk of intravascular cannulation during epidural block—A retrospective analysis of 1117 cases in a medical center

2012 ◽  
Vol 28 (7) ◽  
pp. 373-376 ◽  
Author(s):  
Chih-Kai Shih ◽  
Fu-Yuan Wang ◽  
Chia-Fang Shieh ◽  
Jui-Mei Huang ◽  
I-Cheng Lu ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Medical Center ◽  
Epidural Block

scholarly journals Safety and efficacy of stenting for aortic arch hypoplasia in patients with coarctation of the aorta

2019 ◽  
Vol 28 (3) ◽  
pp. 145-152
Author(s):  
E. G. Warmerdam ◽  
G. J. Krings ◽  
T. A. Meijs ◽  
A. C. Franken ◽  
B. W. Driesen ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Systolic Blood Pressure ◽  
Aortic Arch ◽  
Retrospective Analysis ◽  
Medical Center ◽  
Systolic Pressure ◽  
Coarctation Of The Aorta ◽  
Safety And Efficacy ◽  
Aortic Arch Hypoplasia

Abstract Background Despite a successful repair procedure for coarctation of the aorta (CoA), up to two-thirds of patients remain hypertensive. CoA is often seen in combination with abnormal aortic arch anatomy and morphology. This might be a substrate for persistent hypertension. Therefore, we performed endovascular aortic arch stent placement in patients with CoA and concomitant aortic arch hypoplasia or gothic arch morphology. The goal of this retrospective analysis was to investigate the safety and efficacy of aortic arch stenting. Methods A retrospective analysis was performed in patients who underwent stenting of the aortic arch at the University Medical Center Utrecht. Measurements collected included office blood pressure, use of antihypertensive medication, invasive peak-to-peak systolic pressure over the arch, and aortic diameters on three-dimensional angiography. Data on follow-up were obtained at the date of most recent outpatient visit. Results Twelve patients underwent stenting of the aortic arch. Mean follow-up duration was 14 ± 11 months. Mean peak-to-peak gradient across the arch decreased from 39 ± 13 mm Hg to 7 ± 8 mm Hg directly after stenting (p < 0.001). There were no major procedural complications. Mean systolic blood pressure decreased from 145 ± 16 mm Hg at baseline to 128 ± 9 mm Hg at latest follow-up (p = 0.014). Conclusion This retrospective study shows that stenting of the aortic arch is successful when carried out in a state-of-the-art manner. A direct optimal angiographic and haemodynamic result was shown. No major complications occurred during or after the procedure. At short- to medium-term follow-up a decrease in mean systolic blood pressure was observed.

scholarly journals Timing of surgery following neoadjuvant chemoradiation in rectal cancer: a retrospective analysis from an academic medical center

2019 ◽  
Vol 10 (4) ◽  
pp. 597-604 ◽  
Author(s):  
Seth Maliske ◽  
Justin Chau ◽  
Timothy Ginader ◽  
John Byrn ◽  
Sudershan Bhatia ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Retrospective Analysis ◽  
Medical Center ◽  
Academic Medical Center ◽  
Neoadjuvant Chemoradiation ◽  
Timing Of Surgery ◽  
Academic Medical

Down Syndrome as an Independent Risk Factor for Thrombosis in Children.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 1489-1489 ◽  
Author(s):  
Janna M. Journeycake ◽  
Laura E. Brumley
Keyword(s):  
Down Syndrome ◽  
Risk Factor ◽  
Retrospective Analysis ◽  
Moyamoya Disease ◽  
Arterial Thrombosis ◽  
Independent Risk Factor ◽  
Medical Center ◽  
Case Reports ◽  
Case Series ◽  
Thromboembolic Complications

Abstract Thromboembolic complications in children occur at an estimated rate of 5.3 per 10,000 hospitalized children per year. Over the last decade, investigators have determined that underlying medical conditions such as cancer and congenital heart disease (CHD) and the intensive therapies required to manage these conditions are strongly associated with the thromboembolic complications. Recently, we perceived an increase in the incidence of thrombosis in children with Down Syndrome (DS), a chromosomal abnormality which is associated with both CHD and cancer, but there is very little evidence in the medical literature to suggest that it is an independent risk factor for thrombosis. Although, there are case series describing an association of moyamoya disease and DS, only a few case reports describe venous and arterial thrombosis in children with DS, and there is no information about its rate and severity. Therefore, we conducted a retrospective analysis of patients treated at Children’s Medical Center Dallas between January 1, 2000 and November 30, 2005, hypothesizing that thrombosis would be more prevalent in patients with DS (with or without associated co-morbidities) than in children without DS. ICD-9 codes for CHD, DS, cancer, and thromboembolic complications and the CPT codes for the surgical procedures used to correct CHD were used to identify patients of interest. During the study period, the emergency center, ambulatory outpatient areas, and inpatient units saw 729,324 children. Among these, we identified 511 patients with DS (0.07%), 2168 (0.29%) with CHD, and 1182 (0.16%) with cancer. Sixty-one percent (n=311) of the patients with DS also had CHD, and 2.9% (n=15) had cancer. Thrombosis was identified in 398 (5.4 per 10,000 children). The majority (n=220, 55%) developed deep venous thrombosis (DVT), with catheter-related thrombosis (n= 156) being most common. There were 165 (41%) arterial ischemic strokes (AIS), 19 associated with moyamoya disease. Fifteen children with DS developed thrombosis (rate of 293 per 10, 000 children with DS). Among these 15, DVT occurred in 11 (73%) patients and AIS in 5 (33%), 2 with moyamoya. Among the subgroup of patients diagnosed with AIS, DS was not found to be a risk factor for moyamoya disease (OR 5.6, 95% CI 1.05, 30.5, p=0.1). Two patients with DS (13%) had both DVT and AIS. Children diagnosed with DS (OR 57.5, 95% CI 34.2, 96.5, p<0.0001), CHD (OR 129.5, 95% CI 103, 163, p<0.0001), or cancer (OR 57.3, 95% CI 40, 82, p<0.0001) were more likely to develop thrombosis than children without these three diagnoses. Among the children with CHD, having DS did not increase the odds for thrombosis. However, for children with cancer, DS did increase the odds (OR 9.5, 95% CI 2.7, 33.1, p= 0.007). Four of 15 (27%) children with DS did not have cancer or CHD and still had a higher than expected rate of venous and/or arterial thrombosis (OR 60, 95% CI 23, 156, p< 0.0001). In conclusion, the results of this retrospective analysis indicate that DS may be an independent risk factor for thromboembolic disease during childhood. Prospective studies are needed to confirm these findings and explore potential mechanisms.

Sign in / Sign up

Export Citation Format

Share Document